RNAimmune Revenue and Competitors

Location

$12.4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RNAimmune's estimated annual revenue is currently $1.9M per year.(i)
  • RNAimmune's estimated revenue per employee is $77,500
  • RNAimmune's total funding is $12.4M.

Employee Data

  • RNAimmune has 24 Employees.(i)
  • RNAimmune grew their employee count by 14% last year.

RNAimmune's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CMOReveal Email/Phone
3
Section Chief Medical OfficerReveal Email/Phone
4
Chief Business OfficerReveal Email/Phone
5
Chief Finance OfficerReveal Email/Phone
6
Director Scientific ProgramsReveal Email/Phone
7
Associate Director, ChemistryReveal Email/Phone
8
Sr. Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is RNAimmune?

keywords:N/A

$12.4M

Total Funding

24

Number of Employees

$1.9M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RNAimmune News

2022-04-19 - Codex DNA Demonstrates Simple, Scalable, and Cell-Free ...

RNAimmune will showcase the design and development of their novel Pan-Ras mRNA vaccine for cancer therapy at the conference and also highlight...

2022-03-30 - Money Moves: Meaningful Gigs bagged $6M to grow its ...

RNAimmune also completed a $2.3 million angel round in August of 2020 — the year of its founding — and a $10 million seed round last April. “The...

2022-03-30 - RNAimmune Secures $27 Million Series A Round of ...

RNAimmune is a biopharmaceutical company specializing in discovery and development of messenger RNA (mRNA) therapeutics and vaccines. The...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M24-4%N/A
#2
N/A240%N/A
#3
$2.9M240%$14.3M
#4
$1.7M24-29%$30.4M
#5
$1.7M24-76%N/A